TSTS Receives First International Order Worth $68,000
Good Morning!
$68,000 might seem like a paltry amount of money, and maybe for some it is. But when you are a fledgling company in the nutritional products space, receiving your first order for even $10K is a big deal.
This is why I am not surprised analysts have slapped my latest alert with a big fat “buy now” rating.
TSTS and its proprietary Aqua V Micellization process have gone global and the company will be producing two new products courtesy of a deal signed with an Asia-based network marketing company.
Many believe this is the start of near-term profits for TSTS; which incidentally, already has a product targeting the low testosterone market on the shelves.
I am seeing what the analysts are seeing and it is this:
TSTS won’t remain undervalued for long. The 12-month high is .58 and the slightest hint that it’s ramping up more international orders could send it surging past this ceiling.
Time is of the essence on this one – move on TSTS now.
TSTS Must-See Technicals
TSTS is currently in a short term uptrend. Valuation has rocketed past the 50 DMA of .17.
The play has an uptrending RSI of 74 but remains attractively undervalued. The 12-month high is still way above current valuation.
TSTS recently recorded its first international sale worth $68K. This could be the start of even bigger things to come.
TSTS is currently experiencing a short term uptrend after strong consolidation. Back-to-back higher highs are a strong indicator that an even larger breakout may be looming.
TSTS is on the cusp of breaking through its 13-week high. Next stop is second resistance of .27 where TSTS could test .35.
TSTS has seen breakout volatility in recent trading. Average volume of 170K has seen surpassed two days in a row.
About TSTS
TSTS (That Marketing Solution, Inc.) a development stage company, focuses on the production of products in the nutritional supplements industry.
TSTS acquired the rights to a proprietary formula for a blend of nutritional supplements called Low-T Vitamin Formula capsules that are intended to be a natural, non-FDA regulated, and over-the-counter supplement, which addresses the primary contributing factors of decreased levels of testosterone in males over the age of 30.
TSTS was founded in 2012 and is based in Salt Lake City, Utah.
Global Nutraceuticals Market To Hit $424 Billion By 2017
The global nutraceuticals industry is expected to grow at a considerable CAGR, reaching $424 billion by 2017, due to a strong impetus from ageing population and robust over-the-counter market in different countries.
Latin America is expected to post the highest growth over the span of 2012-2017, inclining at a CAGR of 12.5%. This growth will be majorly on account of increasing demand from Mexico and Brazil, which presently rank amongst the largest producers of the functional food and beverages.
Latest News Development
That Marketing Solution, Inc. (OTCQB: TSTS) Receives First International Order for a Large Network Marketing Company in Asia Totaling $68,000
TSTS recently announced receipt of its first international order from a large network marketing company in Asia to produce two different products.
"We are excited about this order. We anticipate several additional products being launched with this client and a long relationship," said President of TSTS, Matt Smith. "We know we have something unique with our micellized manufacturing process that can give our clients a competitive advantage in the marketplace."
To learn more about TSTS please visit their website: http://www.thatmarketingsolution.com/
TSTS is breakout ready and the only way you are going to capitalize on what it has to offer is if you move on it right now.
Move fast whilst entry is still under 30 cents.